SEC Form 4 · accession 0001104659-15-049835

EPIRUS Biopharmaceuticals, Inc. · EPRS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Executive Officer · Director

Period of report

Jul 2, 2015

Accepted (ET)

Jul 6, 2015 · 4:32 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001135906

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Jul 2, 2015	M	51,200	$1.00	A	120,453	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (Right to Buy)^F1,F3	$1.00	Jul 2, 2015	M	21,273	D	—	Jun 28, 2022	Common Stock	21,273	43,397	D
Employee Stock Option (Right to Buy)^F2,F4	$1.00	Jul 2, 2015	M	7,246	D	—	Dec 20, 2022	Common Stock	7,246	18,639	D
Employee Stock Option (Right to Buy)^F2,F5	$1.00	Jul 2, 2015	M	22,681	D	—	May 14, 2023	Common Stock	22,681	14,860	D

F1The option became exercisable with respect to 25% of the shares on May 18, 2013 and with respect to the remaining shares in substantially equal monthly installments over the remaining 3 years.
F2The option became exercisable with respect to 25% of the shares on December 20, 2013 and with respect to the remaining shares in substantially equal monthly installments over the remaining 3 years.
F3Expiration date corrected from previously reported date of 06/27/2022 to 06/28/2022.
F4Expiration date corrected from previously reported date of 12/19/2022 to 12/20/2022.
F5Expiration date corrected from previously reported date of 05/13/2023 to 05/14/2023.